血液科指南

订阅

MedSci主页 / 所有栏目 / 血液科指南

2021 BSH指南：血红蛋白病和罕见贫血患者铁超载的监测和管理

2021-10-06 英国血液病学学会 British Society for Haematology and John Wiley & Sons Ltd

血红蛋白病

2021年10月，英国血液病学学会(BSH)发布了血红蛋白病和罕见贫血患者铁超载的监测和管理指南。由于定期或间歇性输血或饮食中铁吸收增加引起的铁超载会导致严重的危及生命的并发症。

中文标题：

2021 BSH指南：血红蛋白病和罕见贫血患者铁超载的监测和管理

英文标题：

Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias

发布机构：

英国血液病学学会

发布日期：

2021-10-06

简要介绍：

2021年10月，英国血液病学学会(BSH)发布了血红蛋白病和罕见贫血患者铁超载的监测和管理指南。由于定期或间歇性输血或饮食中铁吸收增加引起的铁超载会导致严重的危及生命的并发症。本文主要针对血红蛋白病和罕见贫血患者铁超载的监测和管理提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=bjh.17839.pdf)] GetToolGuiderByIdResponse(projectId=1, id=4771f1c002200271, title=2021 BSH指南：血红蛋白病和罕见贫血患者铁超载的监测和管理, enTitle=Guidelines for the monitoring and management of iron overload in patients with haemoglobinopathies and rare anaemias, guiderFrom=British Society for Haematology and John Wiley & Sons Ltd, authorId=0, author=, summary=2021年10月，英国血液病学学会(BSH)发布了血红蛋白病和罕见贫血患者铁超载的监测和管理指南。由于定期或间歇性输血或饮食中铁吸收增加引起的铁超载会导致严重的危及生命的并发症。, cover=https://img.medsci.cn/2021108/1633702315267_5579292.jpg, journalId=0, articlesId=null, associationId=1339, associationName=英国血液病学学会, associationIntro=, copyright=0, guiderPublishedTime=Wed Oct 06 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年10月，英国血液病学学会(BSH)发布了血红蛋白病和罕见贫血患者铁超载的监测和管理指南。由于定期或间歇性输血或饮食中铁吸收增加引起的铁超载会导致严重的危及生命的并发症。本文主要针对血红蛋白病和罕见贫血患者铁超载的监测和管理提供指导建议。</span></p>, tagList=[TagDto(tagId=80295, tagName=血红蛋白病)], categoryList=[CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21072, categoryName=梅斯医学-罕见病网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=80295, guiderKeyword=血红蛋白病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8310, appHits=62, showAppHits=0, pcHits=1415, showPcHits=8248, likes=0, shares=9, comments=6, approvalStatus=1, publishedTime=Fri Oct 08 22:12:26 CST 2021, publishedTimeString=2021-10-06, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Oct 08 22:12:11 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 20:03:24 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=bjh.17839.pdf)])
bjh.17839.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1180068, encodeId=76cb118006873, content=英国血液病学学会(BSH), beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Mon Jan 03 16:29:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083852, encodeId=9fa0108385226, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/69f9039e2e2d45169a7ad22e57e5e613/bcc33aed57ce486c8516546641b3f806.jpg, createdBy=1cec6421688, createdName=联通药师, createdTime=Fri Dec 24 11:09:03 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058772, encodeId=8d161058e7258, content=我的积分呢？？？？？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:56 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058771, encodeId=2e171058e710a, content=激动你哦哦轰轰轰明后, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:49 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2022-01-03 一己怀

    英国血液病学学会(BSH)

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1180068, encodeId=76cb118006873, content=英国血液病学学会(BSH), beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Mon Jan 03 16:29:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083852, encodeId=9fa0108385226, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/69f9039e2e2d45169a7ad22e57e5e613/bcc33aed57ce486c8516546641b3f806.jpg, createdBy=1cec6421688, createdName=联通药师, createdTime=Fri Dec 24 11:09:03 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058772, encodeId=8d161058e7258, content=我的积分呢？？？？？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:56 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058771, encodeId=2e171058e710a, content=激动你哦哦轰轰轰明后, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:49 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-12-24 联通药师

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1180068, encodeId=76cb118006873, content=英国血液病学学会(BSH), beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Mon Jan 03 16:29:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083852, encodeId=9fa0108385226, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/69f9039e2e2d45169a7ad22e57e5e613/bcc33aed57ce486c8516546641b3f806.jpg, createdBy=1cec6421688, createdName=联通药师, createdTime=Fri Dec 24 11:09:03 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058772, encodeId=8d161058e7258, content=我的积分呢？？？？？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:56 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058771, encodeId=2e171058e710a, content=激动你哦哦轰轰轰明后, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:49 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-10-08 ms1000001191450835

    我的积分呢？？？？？

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1180068, encodeId=76cb118006873, content=英国血液病学学会(BSH), beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Mon Jan 03 16:29:34 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083852, encodeId=9fa0108385226, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211224/69f9039e2e2d45169a7ad22e57e5e613/bcc33aed57ce486c8516546641b3f806.jpg, createdBy=1cec6421688, createdName=联通药师, createdTime=Fri Dec 24 11:09:03 CST 2021, time=2021-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058772, encodeId=8d161058e7258, content=我的积分呢？？？？？, beContent=null, objectType=guider, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:56 CST 2021, time=2021-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1058771, encodeId=2e171058e710a, content=激动你哦哦轰轰轰明后, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9aec5620137, createdName=ms1000001191450835, createdTime=Fri Oct 08 23:56:49 CST 2021, time=2021-10-08, status=1, ipAttribution=)]
    2021-10-08 ms1000001191450835

    激动你哦哦轰轰轰明后

    0

拓展阅读

2023 BSH 指南：严重血红蛋白病的筛查和诊断

英国血液病学学会(BSH,British Society for Haematology) · 2023-04-19

英国血液学学会指南：严重血红蛋白病的诊断和筛查指南

英国血液学会 (BSH) · 2023-06-05